114 related articles for article (PubMed ID: 2186331)
1. The ocular effects of intracarotid bromodeoxyuridine and radiation therapy in the treatment of malignant glioma.
Vander JF; Kincaid MC; Hegarty TJ; Page M; Averill D; Junck L; Greenberg HS
Ophthalmology; 1990 Mar; 97(3):352-7. PubMed ID: 2186331
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
Hegarty TJ; Thornton AF; Diaz RF; Chandler WF; Ensminger WD; Junck L; Page MA; Gebarski SS; Hood TW; Stetson PL
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):421-8. PubMed ID: 2168357
[TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous complications of intraarterial 5-bromodeoxyuridine and radiation.
McCuaig CC; Ellis CN; Greenberg HS; Hegarty TJ; Page MA
J Am Acad Dermatol; 1989 Dec; 21(6):1235-40. PubMed ID: 2584461
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
Greenberg HS; Chandler WF; Diaz RF; Ensminger WD; Junck L; Page MA; Gebarski SS; McKeever P; Hood TW; Stetson PL
J Neurosurg; 1988 Oct; 69(4):500-5. PubMed ID: 3047341
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
Greenberg HS; Chandler WF; Ensminger WD; Sandler H; Junck L; Page MA; Crane D; McKeever P; Tankanow R; Bromberg J
Neurology; 1994 Sep; 44(9):1715-20. PubMed ID: 7936303
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors.
Matsutani M; Kohno T; Nagashima T; Nagayama I; Matsuda T; Hoshino T; Sano K
Radiat Med; 1988; 6(1):33-9. PubMed ID: 3045898
[TBL] [Abstract][Full Text] [Related]
7. [Chemical modifiers in radiotherapy].
Nagashima T; Takakura K
Gan No Rinsho; 1989 Sep; 35(11):1369-71. PubMed ID: 2681875
[TBL] [Abstract][Full Text] [Related]
8. [A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
Kawano H; Hayashi M; Satoh K; Ishii H; Nakatsugawa S; Ishii Y
No To Shinkei; 1989 Nov; 41(11):1071-5. PubMed ID: 2620008
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiation and intracarotid cisplatin infusion in malignant gliomas: a feasibility study.
Fountzilas G; Karavelis A; Makrantonakis P; Selviaridis P; Tzitzikas J; Kalogera-Fountzila A; Hatzibaloglou A; Karkavelas G; Foroglou G; Tourkantonis A
Am J Clin Oncol; 1997 Apr; 20(2):138-42. PubMed ID: 9124186
[TBL] [Abstract][Full Text] [Related]
10. [AUFRAP therapy: combined modality treatment of malignant gliomas with intraarterial infusion of ACNU].
Wakisaka S; Maruoka N; Kaji Y; Moriyama T; Oyama H; Shimauchi M; Nonaka A; Goya T; Kinoshita K; Kodama T
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2405-9. PubMed ID: 3137877
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
12. [Radio-chemotherapy of inoperable malignant brain gliomas].
Sciacero P; Cugini A; Geda C; Andreotti M; Ferrari G
Radiol Med; 1987; 73(1-2):96-8. PubMed ID: 3809641
[TBL] [Abstract][Full Text] [Related]
13. Integrative treatment of gliomas.
Sano K
Clin Neurosurg; 1983; 30():93-124. PubMed ID: 6199151
[No Abstract] [Full Text] [Related]
14. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
Levin VA; Wilson CB; Davis R; Wara WM; Pischer TL; Irwin L
J Neurosurg; 1979 Oct; 51(4):526-32. PubMed ID: 225456
[No Abstract] [Full Text] [Related]
15. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial 5-bromo-2-deoxyuridine (BUdR) radiosensitization with external beam radiation in rhesus monkeys: toxicity study.
Greenberg HS; Chandler WF; Diaz RF; Averill DR; Gebarski SS; Lichter AS; Ensminger WD
J Neurooncol; 1988 Dec; 6(4):349-54. PubMed ID: 3221261
[TBL] [Abstract][Full Text] [Related]
17. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
[TBL] [Abstract][Full Text] [Related]
18. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
Phuphanich S; Levin EM; Levin VA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
